New combination between 4-{3-[Cis-Hexahydrocyclopenta[c]Pyrrol-2(1H)-yl]Propoxy}Benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it

New Combination Between 4-{3-[Cis-hexahydrocyclopenta[c]pyrrol 2(1H)-yl]propoxy}benzamide and an NMDA Receptor Antagonist, and Pharmaceutical Compositions Containing It Abstract A combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide of formula (I): or an addition sa...

Full description

Saved in:
Bibliographic Details
Main Authors TROCME-THIBIERGE, CARYN, SORS, AURORE, MERDES, ANNETTE
Format Patent
LanguageEnglish
Published 27.06.2013
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:New Combination Between 4-{3-[Cis-hexahydrocyclopenta[c]pyrrol 2(1H)-yl]propoxy}benzamide and an NMDA Receptor Antagonist, and Pharmaceutical Compositions Containing It Abstract A combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist. Medicaments are also disclosed.
Bibliography:Application Number: AU20120258339